CYBERDYNE Online Store

🔍

PRESS RELEASES BACK NUMBER

SEARCH
2021-08-31
【IR News】Notice regarding the acquisition of C2, developer of smartphone app “JUKUSUI”
2021-08-30
【News】CYBERDYNE listed Medical HAL Single Joint Type to U.S. FDA as Class I Medical Device
2021-08-26
【News】Notice of application for the additional indication of Medical HAL for Spastic Paraplegia including HTLV-1 Associated Myelopathy (HAM)
2021-08-12
【News】Medical HAL introduced to one of the largest hospital in France
2021-08-11
【News】Medical HAL installed to largest hospital in the Basque region, Spain
2021-08-05
【News】Formed a capital and business alliance with KanonCure, a company that develops cell sheets for the treatment of liver diseases
2021-07-30
【News】Business alliance with J-Workout, the largest gym specializing in spinal cord injury
2021-07-26
【News】Details report of the investigator-initiated clinical trial of Medical HAL for neuromuscular disease patients published in an international medical journal
2021-07-15
【News】CYBERDYNE joins Nippon Keidanren
2021-06-23
【News】Preliminary results of Medical HAL Lower Limb Type stroke clinical trial
2021-06-04
【News】 HAL at Home, 29,800-yen trial campaign for the first month
~ Supports functional recovery from disease/injuries and prevents frailty in the elderly~
2021-05-24
【News】 Capital and Business Alliance with Rehab for JAPAN
2021-05-12
【News】A collaborative research paper on Acoustic X with Cambridge University is published
2021-05-10
【News】HAL installed to the largest public hospital in Indonesia
2021-04-30
【News】Opening of RoboFit as the first Cybernics Treatment Center in Australia
2021-04-09
【News】Disinfection Cleaning Robot Certified as Tsukuba Quality
2021-04-05
【News】Capital and Business Alliance with Allm
2021-03-31
【Campaign 】HAL at Home campaign that guarantees a full refund in case of dissatisfaction
2021-03-30
【News】HAL Single Joint Type receives medical device approval from Thai FDA
2021-03-29
【News】Grand Opening of Cybernics Treatment Center in Taiwan
BACK TO TOP

© 2024 CYBERDYNE INC. ALL RIGHTS RESERVED.